🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
56.46
-5.64 (-9.08%)
Nov 20, 2026, 4:00 PM EST - Market closed

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
926.30M891.30M938.50M
Germany Revenue
292.80M297.00M310.70M
Europe excluding Germany Revenue
1.03B950.20M873.00M
China Revenue
442.30M475.80M471.20M
Rest of Asia Pacific Revenue
532.60M552.60M518.50M
Total Asia Pacific Revenue
974.90M1.03B989.70M
Other Countries Revenue
284.40M269.60M254.50M
Revenue (Total)
3.51B3.44B3.37B

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
BSI BioSpin Revenue
1.06B878.80M905.70M
BSI CALID Revenue
1.09B1.21B1.09B
BSI Life Science Revenue
2.15B2.09B2.00B
BSI Nano Revenue
1.08B1.08B1.10B
Total BSI Revenue
3.23B3.17B3.10B
BEST Revenue
294.70M270.90M283.00M
Eliminations from Revenue
-10.30M-7.70M-14.10M
Revenue (Total)
3.51B3.44B3.37B

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
BSI BioSpin Operating Income
-104.30M157.80M
BSI CALID Operating Income
-153.30M180.00M
BSI Life Science Operating Income
-257.60M337.80M
BSI Nano Operating Income
--71.80M2.30M
Corporate, Eliminations and Other Operating Income
--137.00M-121.90M
Total BSI Operating Income
-48.80M218.20M
BEST Operating Income
-19.40M34.90M
Operating Income (Total)
-69.80M68.20M253.10M

Capital Expenditures

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
BSI BioSpin Capital Expenditures
11.40M22.80M
BSI CALID Capital Expenditures
25.30M34.10M
BSI Life Science Capital Expenditures
36.70M56.90M
BSI Nano Capital Expenditures
36.50M19.30M
Corporate Capital Expenditures
16.00M14.80M
Total BSI Capital Expenditures
89.20M91.00M
BEST Capital Expenditures
13.80M24.30M